The weekly litigation news digest is live. Subscribe now

IP Verse

Modified Release Orally Administered Amino Acid Formulations - EP4129270

The patent EP4129270 was granted to APR Applied Pharma Research on Sep 11, 2024. The application was originally filed on Sep 27, 2016 under application number EP22178328A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4129270

APR APPLIED PHARMA RESEARCH
Application Number
EP22178328A
Filing Date
Sep 27, 2016
Status
Granted And Under Opposition
Aug 8, 2024
Publication Date
Sep 11, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDJun 10, 2025MAIWALDADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP1360904
OPPOSITIONEP2468261
OPPOSITIONUS2002004072
OPPOSITIONUS2013251803
OPPOSITIONWO2016112170
SEARCHEP1774858
SEARCHGB1217365
SEARCHWO0067797
SEARCHWO2011043647
SEARCHWO2016112170

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents